FDA Inspection 1264907 — LTS Lohmann Therapie-Systeme AG
The FDA completed an inspection of LTS Lohmann Therapie-Systeme AG on May 18, 2022 in Andernach. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 18, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Andernach (Germany)
Additional Details
Mutual Recognition Agreement (MRA)